A specialist in analytical technologies, the company introduced the 3200 MD system, the first of a family of in vitro diagnostic devices to identify inorganic or organic compounds in human specimens for clinical use – and now the firm is introducing to Europe a series of reagent kits to harness this advanced technology for routine clinical applications.
‘The lead test in the Sciex IVD-MS portfolio is focused on vitamin D analysis. This kit is designed to help clinicians make diagnoses of vitamin D deficiencies, with the ability to quantitate both 25-0H-Vitamin 02 and 25-0H-Vitamin 03 in a single run,’ AB Sciex points out. ‘Adequate levels of vitamin D have been known for decades to be essential for strong bones. Recent research has linked vitamin D to be important in the prevention of multiple common and serious diseases, such as type 1 diabetes, cancer and heart disease.’
Rainer Blair, President of AB Sciex: ‘With the new family of Sciex IVD-MS reagent kits, coupled with our 3200MD CE-IVD instrumentation, we can provide complete solutions to European hospitals and clinical laboratories to improve diagnostics.’
The new Sciex IVD-MS Kits work with the AB Sciex 3200MD CE-IVD series of MS systems, including the API 3200MD and 3200MD Q-TRAP LC/MS/MS systems, recently launched in Europe. ‘The 3200MD systems are sensitive and specific for the analytes most commonly requested in screening programmes, routine testing and research projects in a number of key areas of clinical diagnostics,’ the firm explains, adding: ‘Designed as compact bench top systems, the instruments are robust, easy-to-use tools that are rugged enough for continuous high-throughput operation. Intuitive software and a full complement of automation features enable these systems to fit seamlessly into the workflows of any clinical diagnostic laboratory.’